US 9463193
Individual 5-fluorouracile dose optimization in folfiri treatment
granted A61KA61K31/4745A61K31/513
Quick answer
US patent 9463193 (Individual 5-fluorouracile dose optimization in folfiri treatment) held by INSTITUT DE CANCEROLOGIE DE L'OUEST expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Grant date
- Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/4745, A61K31/513, A61K31/519, A61K39/39558